239 related articles for article (PubMed ID: 26527526)
1. "OMICS" technologies and their role in foregut primary malignancies.
Farid SG; Morris-Stiff G
Curr Probl Surg; 2015 Oct; 52(10):409-41. PubMed ID: 26527526
[No Abstract] [Full Text] [Related]
2. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
Likhitrattanapisal S; Tipanee J; Janvilisri T
Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818
[TBL] [Abstract][Full Text] [Related]
3. [What can be done for patients with cancer of the digestive tract in 2003? Guidelines of the Francophone Federation of Digestive Tract Cancerology--part II].
Conseil Scientifique de La FFCD
Gastroenterol Clin Biol; 2003 Jan; 27(1):43-58. PubMed ID: 12594364
[No Abstract] [Full Text] [Related]
4. [Oncologic markers in the diagnosis of malignant tumors of the digestive tract].
Maĭstrenko NA; Kurygin AA; Khrykov GN
Vestn Khir Im I I Grek; 2002; 161(4):102-6. PubMed ID: 12577567
[No Abstract] [Full Text] [Related]
5. The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology.
Ferrone CR; Ting DT; Shahid M; Konstantinidis IT; Sabbatino F; Goyal L; Rice-Stitt T; Mubeen A; Arora K; Bardeesey N; Miura J; Gamblin TC; Zhu AX; Borger D; Lillemoe KD; Rivera MN; Deshpande V
Ann Surg Oncol; 2016 Jan; 23(1):290-6. PubMed ID: 25519926
[TBL] [Abstract][Full Text] [Related]
6. A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma.
Collins AL; Wojcik S; Liu J; Frankel WL; Alder H; Yu L; Schmittgen TD; Croce CM; Bloomston M
Ann Surg Oncol; 2014 Jan; 21(1):133-8. PubMed ID: 24046106
[TBL] [Abstract][Full Text] [Related]
7. Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as "cholangioblastic variant of intrahepatic cholangiocarcinoma".
Braxton DR; Saxe D; Damjanov N; Stashek K; Shroff S; Morrissette JD; Tondon R; Furth EE
Hum Pathol; 2017 Apr; 62():232-241. PubMed ID: 28232156
[TBL] [Abstract][Full Text] [Related]
8. Telomerase reactivation is associated with hepatobiliary and pancreatic cancers.
Sansone V; Le Grazie M; Roselli J; Polvani S; Galli A; Tovoli F; Tarocchi M
Hepatobiliary Pancreat Dis Int; 2020 Oct; 19(5):420-428. PubMed ID: 32386990
[TBL] [Abstract][Full Text] [Related]
9. Circulating miR-21 as a potential biomarker in human digestive system carcinoma: a systematic review and diagnostic meta-analysis.
Aalami AH; Abdeahad H; Mesgari M
Biomarkers; 2021 Mar; 26(2):103-113. PubMed ID: 33434077
[No Abstract] [Full Text] [Related]
10. The functional role of long non-coding RNA in digestive system carcinomas.
Wang GY; Zhu YY; Zhang YQ
Bull Cancer; 2014 Sep; 101(9):E27-31. PubMed ID: 25295496
[TBL] [Abstract][Full Text] [Related]
11. Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma.
Liu B; Hervé J; Bioulac-Sage P; Valogne Y; Roux J; Yilmaz F; Boisgard R; Guettier C; Calès P; Tavitian B; Samuel D; Clerc J; Bréchot C; Faivre J
Gastroenterology; 2007 Apr; 132(4):1495-503. PubMed ID: 17408651
[TBL] [Abstract][Full Text] [Related]
12. Overlapping signature genes between hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Chen F; Li S; Castranova V
Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1320-1. PubMed ID: 19826380
[No Abstract] [Full Text] [Related]
13. Advanced mass spectrometry-based multi-omics technologies for exploring the pathogenesis of hepatocellular carcinoma.
Nie W; Yan L; Lee YH; Guha C; Kurland IJ; Lu H
Mass Spectrom Rev; 2016; 35(3):331-49. PubMed ID: 24890331
[TBL] [Abstract][Full Text] [Related]
14. The role of microRNAs in liver cancer.
Papaconstantinou I; Karakatsanis A; Gazouli M; Polymeneas G; Voros D
Eur J Gastroenterol Hepatol; 2012 Mar; 24(3):223-8. PubMed ID: 22228372
[TBL] [Abstract][Full Text] [Related]
15. [Gastroenterological Cancer Diagnosis by Metabolomics-Discovery of Pancreatic Cancer Biomarker].
Yoshida M; Nishiumi S; Azuma T
Rinsho Byori; 2015 Apr; 63(4):450-6. PubMed ID: 26536778
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel DNA methylation biomarker panels for the diagnosis and differentiation between common adenocarcinomas and their liver metastases.
Draškovič T; Hauptman N
Sci Rep; 2024 Feb; 14(1):3095. PubMed ID: 38326602
[TBL] [Abstract][Full Text] [Related]
17. [Early diagnosis of cancer of the digestive tract].
Acta Gastroenterol Latinoam; 1977 Aug; 7(2):113-22. PubMed ID: 930524
[No Abstract] [Full Text] [Related]
18. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
[TBL] [Abstract][Full Text] [Related]
19. Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas.
Somorácz A; Tátrai P; Horváth G; Kiss A; Kupcsulik P; Kovalszky I; Schaff Z
Hum Pathol; 2010 Sep; 41(9):1310-9. PubMed ID: 20471664
[TBL] [Abstract][Full Text] [Related]
20. [Gene TP53 and digestive cancers].
Tominaga O; Salmon RJ; Laurent-Puig P
Gastroenterol Clin Biol; 1993; 17(3):187-96. PubMed ID: 8392475
[No Abstract] [Full Text] [Related]
[Next] [New Search]
